Eli Lilly-backed biotech companies HJB and MabSpace have agreed to merge into a newly formed business called Transcenta.

Oncology drug developer MabSpace Biosciences and biotherapeutics developer Hangzhou Just Biotherapeutics, both China-based companies backed by pharmaceutical firm Eli Lilly, have agreed to merge to create a company dubbed Transcenta. HJB was formed in 2016 by¬†US-based biotherapeutics technology producer Just Biotherapeutics to develop biosimilars and original treatments for conditions including cancer, rare genetic diseases and…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.